PULmonary DAMage after hospitalization for acute COvid-19 (PULDAMCO), an exploratory prospective cohort study
Recruiting
- Conditions
- COVID-19
- Registration Number
- NL-OMON23357
- Lead Sponsor
- Radboudumc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 150
Inclusion Criteria
? Hospital admission for COVID-19
? CT during admission with CO-RADS >=3
? Informed consent
Exclusion Criteria
? Age < 18
? Pregnancy
? Renal failure (MDRD < 30 ml/kg/1,73m^2)
? Allergic reaction to iodine containing intravenous contrast media
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method -Prevalence of residual lung damage (per type) at 3 and 12 month<br>-Estimated percentage of lung parenchyma affected by various types of diffuse lung damage (e.g., ground glass, consolidation, perfusion abnormalities)<br>-Number of lung segments affected by focal lung damage (e.g., traction bronchiectasis, residual lung emboli)<br>-Predictors of pulmonary damage after acute COVID-19
- Secondary Outcome Measures
Name Time Method